ABSTRACT This report describes the establishment directly from normal preimplantation mouse embryos of a cell line that forms teratocarcinomas when injected into mice. The pluripotency of these embryonic stem cells was demonstrated conclusively by the observation that subclonal cultures, derived from isolated single cells, can differentiate into a wide variety of cell types. Such embryonic stem cells were isolated from inner cell masses of late blastocysts cultured in medium conditioned by an established teratocarcinoma stem cell line. This suggests that such conditioned medium might contain a growth factor that stimulates the proliferation or inhibits the differentiation of normal pluripotent embryonic cells, or both. This method of obtaining embryonic stem cells makes feasible the isolation of pluripotent cells lines from various types of noninbred embryo, including those carrying mutant genes. The availability of such cell lines should make possible new approaches to the study of early mammalian development.
gle cells, can differentiate into a wide variety of cell types. Such embryonic stem cells were isolated from inner cell masses of late blastocysts cultured in medium conditioned by an established teratocarcinoma stem cell line. This suggests that such conditioned medium might contain a growth factor that stimulates the proliferation or inhibits the differentiation of normal pluripotent embryonic cells, or both. This method of obtaining embryonic stem cells makes feasible the isolation of pluripotent cells lines from various types of noninbred embryo, including those carrying mutant genes. The availability of such cell lines should make possible new approaches to the study of early mammalian development. Teratocarcinomas are tumors that arise with relatively high efficiency when normal 1-to 7.5-day-old inbred mouse embryos are transplanted to an extra-uterine site in a histocompatible host (1, 2) . The stem cell lines that are isolated from them are known as embryonal carcinoma cell (ECC) lines. Such cells have morphological, biochemical, and immunological properties in common with pluripotent embryonic cells and therefore have been used extensively as an in vitro model system for the study of the developing embryo (3) (4) (5) . In some cases these properties include the ability to differentiate in vitro in a manner that closely parallels the normal behavior of the isolated embryonic inner cell mass (ICM) (6, 7 (8, 9) . These findings, schematically represented in Fig. 1 , raise questions about the origin ofthe teratocarcinoma stem cell. One hypothesis is that the tumor stem cells arise as a consequence of a stable, but reversible, epigenetic change in normal pluripotent embryonic cells. Such "transformed" cells presumably continue proliferation in the undifferentiated state because neoplastic conversion has reduced their efficiency of response to the normal signals for differentiation (11) . An (14) .
All experiments involving ICM-derived cells were carried out in DME medium supplemented with 10% calf serum and 0.1 mM 2-mercaptoethanol. When conditioned medium was used, the concentrated material described above was diluted 1:4 in (17) that the autostimulatory growth factor(s) produced by certain tumor cells might be the product of a gene normally expressed by embryonic cells.
Medium conditioned by the PSA-1 embryonal carcinoma cell line was prepared and concentrated as described in Materials and Methods. ICMs were isolated from normal late mouse blastocysts, and approximately 30 of these were seeded on a confluent fibroblastic feeder layer in this conditioned medium. Within 1 week, four colonies of cells appeared. These showed a remarkable resemblance to those formed when the pluripotent PSA-1 embryonal carcinoma cell line is cultured on a fibroblastic feeder layer (see Fig. 2 ). These embryo-derived colonies were passaged to a fresh feeder layer in conditioned medium, and within 1 week this secondary culture contained a very large number of embryonal carcinoma-like colonies. In contrast, control cultures of ICM-derived colonies grown and passaged in the absence ofconditioned medium did not contain continuously proliferating embryonal carcinoma-like cell colonies. The cells growing in conditioned medium were subsequently passaged at approximately weekly intervals until a mass culture was obtained. As derived from teratocarcinomas. The specific cell line described here was designated ESC-ICR.
The mass cultures of ESC-ICR cells have a growth rate similar to that of PSA-1 cells and are morphologically identical to undifferentiated PSA-1 cells, both in the presence and absence of fibroblastic feeder cells (see Fig. 2 ). In addition, like many embryonal carcinoma cell lines, ESC-ICR cells are diploid. Preliminary examination of G-banded chromosome spreads indicates that at least some ofthe cells in the culture have a normal female karyotype, with the exception of a possible deletion of the distal portion of one of the two X chromosomes.
In view of the fact that ESC-ICR cells are morphologically indistinguishable from the PSA-1 teratocarcinoma stem cells used to condition the medium in which they were grown, it was obviously necessary to demonstrate that the former did not arise by accidental contamination of the embryo cultures with PSA-1 cells. The embryos from which the ESC-ICR cells were isolated were obtained by mating random-bred ICR female mice with males ofthe inbred SWR/J strain. Random-bred ICR mice segregate the glucosephosphate isomerase alleles Gpi-la and Gpi-lb, whereas SWR/J mice are homozygous for Gpi-lb. (ICR X SWR/J)Fl hybrids must therefore be either Gpi-lb homozygotes or Gpi-la/b heterozygotes. In contrast, the PSA-1 cell line (and all other embryonal carcinoma cell lines currently being cultured in this laboratory) are homozygous for Gpi-la. Therefore, ifthe ESC-ICR cells produce the electrophoretically faster form ofthe enzyme glucosephosphate isomerase encoded by the Gpi-lb gene, they could not have arisen by contamination of the embryo cultures with established embryonal carcinoma cells. The results ofelectrophoresis and staining for glucosephosphate isomerase activity (18) , shown in Fig. 3 5 X 106 ESC-ICR cells. In most cases a typical teratocarcinoma, containing derivatives of all three primary germ layers, formed within 6 weeks. These results indicated that the ESC-ICR cells are similar to embryonal carcinoma cells in their ability to form tumors and suggested that the embryo-derived cells are pluripotent. To prove this, single ESC-ICR cells were isolated in microdrops and subelonal cultures were established from them (19) . Although the cloning efficiency of the ESC-ICR cells was rather low (approximately 1% as compared with at least 10% for PSA-1 cells), four single cell clones were obtained. Each clone was tested for its ability to differentiate by injection into athymic mice, and each was found to form typical teratocarcinomas (Fig.  4) containing several differentiated cell types, including endoderm and connective and epithelial tissues, as well as undifferentiated stem cells. These results conclusively demonstrate that individual cells in the ESC culture are pluripotent.
Embryonic stem cells and their clonal derivatives were also found to be capable of differentiation in vitro when cultured under conditions appropriate for the differentiation of PSA embryonal carcinoma cells (6, 7, 16) . When the ESC-ICR cells, which are maintained in the undifferentiated state by coculture with fibroblastic feeder cells, are plated in the absence offeeder cells they form homogeneous rounded aggregates that, when placed in suspension, differentiate an outer layer of endodermlike cells. These two-layered structures are known as embryoid bodies because of their similarity to the fetus-forming ICM of the normal mouse embryo (6) bodies to reattach to a collagen-coated tissue culture substratum. Within a few days of replating, several morphologically distinct cell types are observed migrating away from the attached embryoid body cores, and within 6 weeks such cultures contain a wide variety of differentiated cell types. Fig. 5 illustrates some of these, including giant cells, neuron-like cells, endodermal cells, cartilage, and a series of highly structured tubules.
DISCUSSION
The observations described above demonstrate that ICMs isolated from normal mouse blastocysts and cultured in medium conditioned by an established embryonal carcinoma cell line can give rise to cultures of cells with the characteristics of mouse teratocarcinoma stem cells. These properties include cell morphology, pluripotency, and the ability to form typical teratocarcinomas when injected into mice. In addition, it has been found that the embryonic stem cells described here express the SSEA-1 cell surface antigen (20) common to teratocarcinoma stem cells and early embryos but not expressed by -most differentiated cell types (data not shown).
By using this culture method, it should now be possible to examine in vitro the way in which normal early embryonic cells give rise to teratocarcinoma stem cells. The results ofsuch studies may ultimately serve to resolve the controversy surrounding the identity ofteratocarcinoma stem cell progenitors in the early embryo and the question ofwhether the tumor stem cells have undergone a process of neoplastic transformation.
These experiments were undertaken on the premise that medium conditioned by teratocarcinoma stem cells might contain a factor, perhaps identical to a normal endogenous embryonic growth factor, capable of stimulating the proliferation of a small population of pluripotent cells in the normal embryo. The success of the approach reported here suggests that this working hypothesis has some validity. Although little is known at present about this factor, it seems unlikely that it is commonly produced by other cell types; fibroblastic feeder layers are generally considered potent conditioning agents, but in these experiments ICMs cultured on STO feeder layers did not give rise to ESC cells unless teratocarcinoma-conditioned medium was present in the early phases ofthe culture procedure. Obviously many questions remain to be answered about the teratocarcinoma-derived factor. Its purification will be difficult because the biological assay for its activity involves the growth of cells from isolated mouse embryonic ICMs. It is nevertheless interesting to speculate on its possible relationship to other known tumor-derived growth factors (17, 21) . Ultimately the information that is obtained about this factor should help to elucidate the mechanism by which growth and differentiation are regulated during embryonic development.
The culture method described here, as well as the one recently reported by Evans and Kaufman (12) , also has immediate practical value for the isolation of new pluripotent stem cell lines. It provides a means of circumventing the need for "converting" an embryo to a tumor in vivo. This makes feasible the isolation of pluripotent cells from embryos that cannot directly form teratocarcinomas when they are transplanted to an extrauterine site. These include all noninbred embryos because, for reasons that are not yet understood, stem-cell-containing teratocarcinomas can be obtained only when an embryo is transplanted to a histocompatible host; the alternative approach of obtaining stem-cell-containing teratocarcinomas by transplanting embryos to immunodeficient athymic mice has not been generally successful (2, 22) . Many interesting mutations that affect early embryonic development are not maintained in inbred stocks of mice, and it has therefore not been feasible to obtain teratocarcinomas from embryos carrying these mutant genes. In this context it is noteworthy that the pluripotent ESC line described here was isolated from embryos of a noninbred genotype and thus is derived from an embryo that would not otherwise give rise to a teratocarcinoma. Given these results, it seems likely that there will soon be available pluripotent, embryo-derived cell lines with specific genetic alterations that should make possible a variety of new approaches to the study of early mammalian development.
Note Added in Proof. The method of ESC isolation described here has now been used to establish cell cultures from embryos homozygous for the t"5 mutation of the T/t-complex. 
